Company Filing History:
Years Active: 2018-2024
Title: KyuOk Jeon: Innovator in Cancer Research
Introduction
KyuOk Jeon is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on Mcl-1 inhibitors. With a total of 4 patents, his research focuses on developing compounds that can potentially treat various cancers.
Latest Patents
KyuOk Jeon's latest patents include the development of substituted indole Mcl-1 inhibitors. These compounds are designed to inhibit the activity of the anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The patents also detail pharmaceutical compositions and methods for using these compounds to treat diseases characterized by the over-expression or dysregulation of Mcl-1 protein, such as cancer.
Career Highlights
KyuOk Jeon is affiliated with Vanderbilt University, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to advancing medical science.
Collaborations
Some of his notable coworkers include Stephen W. Fesik and Edward T. Olejniczak. Their collaborative efforts contribute to the innovative research environment at Vanderbilt University.
Conclusion
KyuOk Jeon is a key figure in the field of cancer research, with a focus on developing Mcl-1 inhibitors. His contributions through patents and collaborations highlight the importance of innovation in the fight against cancer.